Rachel Krevans is chair of the firm's Intellectual Property Litigation Practice Group and co-chair of the firm's Intellectual Property Practice Group. For more than 20 years, Ms. Krevans has tried patent disputes involving all manner of products in the electronics and biosciences areas. Her work in these industries has involved an assortment of technologies-from DVRs, cable and satellite TV, and computer-phone interfaces, to HIV and cancer treatments, vaccines, and blood and antibody research.
Ms. Krevans's contentious matters often involve some of the most difficult and complex circumstances. Take for example the rare defense jury verdict in favor of her client EchoStar in the Eastern District of Texas in 2007. At the time of the trial, plaintiff Forgent was seeking $205 million in damages. Her winning trial strategy created a new model for defending patent cases in the Eastern District of Texas.
Another recent and complex case involved her client Bayer in a patent infringement matter against Abbott Diabetes Care in the Northern District of California. After Bayer won summary judgment on one of the two patents, the case was quickly reassigned to a new judge, who set a six-week timeline for a trial on the second patent. Bayer won at trial, prevailing on both patents and all asserted claims.
Chambers notes Ms. Krevans as “one of the most thorough, calculating and technically astute IP lawyers around” and says “the powerful scientific mind of Rachel Krevans has impressed clients in the life sciences industry.” In 2013, Chambers USA Women in Law honored her as "IP Lawyer of the Year."